Member Log In
Leading Bioscience Venture Capital Firms as well as Bioscience Angel Investors to talk funding strategies and trends
To keep research and development moving forward, funding strategies consume founders and executive leaders of early-stage bioscience companies. It’s so important that six different sessions at the BIO Alabama Virtual Annual Conference will focus on funding. From seed to SBIR/STTR grants and venture capital to merger & acquisitions, the conference will feature topics for each stage of the funding cycle. Register today to gain access to:
Three funding focused sessions on Tuesday, October 6:
At 9:00 a.m. CST - Bioscience Investors Forum: The pandemic changed many things including capital investment. Join this session, in partnership with Southeast Life Sciences, to hear from leading bioscience venture capital firms regarding trends in bioscience investment:
Benjamin Scruggs, Ph.D., Associate, Hatteras Venture Partners
Matthew Miessau, Associate, Epidarex Capital
Ali Behbahani, MD, General Partner, New Enterprise Associates
At 10:00 a.m. CST - Merger & Acquisition Strategy: What Entrepreneurs need to know will feature M&A expert Michael White with Founders Advisors. Learn more about your end game strategy, when and how to start planning, and what you can expect as you move through strategy development, due diligence, and across the finish line.
At 11:00 a.m. CST - SBIR/STTR Grants: If grants are a part of your funding strategy, Rachel Lane, PhD, Founder of The Written Science and Erik Schwiebert, PhD, CEO and Chief Scientific Officer at Discovery BioMed, are two people to know in Alabama. Dr. Lane paired and Dr. Schwiebert will bring award winning tips and advice based on their own experience and success for you to incorporate into your next proposal.
On Wednesday, October 7, there are 3 additional funding sessions including:
At 1:00 p.m. CST - hear real stories from Founders and Funders. Miller Girvin, panel moderator and CEO of Alabama Capital Network, along with Greg Schmergel, Chairman of Yuva Biosciences; Bob Shufflebarger, CEO of TriAltus Bioscience; Neill Wright, President and CEO of Bronze Valley; and Charlie Perry, Private Investor, will deliver a candid discussion all about the road to funding.
At 2:00 p.m. CST - Bioscience Angel Investor Forum: Angel investors are investing in bioscience and providing necessary early-stage seed capital. But, understanding the role of angel investors and how to prepare for an angel investor is key. Hear directly from bioscience angel investors including:
James Childs, panel moderator, Partner, Maynard Cooper Gale
Tommy Satterfield, Private Investor
Daniel Coleman, Private Investor
At 3:00 p.m. CST - We will bring all the funding strategies together with a session focused on investor relations. Stephanie Carrington, Managing Director at Westwicke, will share her expert advice on building and maintaining relationships with investors during Securing your first institutional round: Inside investor relations.
Additional speakers, organizations, as well as sponsors, can be found on the official conference website. Up-to-date information on the agenda and thought leaders presenting can be found on the conference website. Event registration is open.
100 Drake Dr., Unit 688Normal, AL 35762
© BIO Alabama